Dearborn Partners LLC Has $30.47 Million Stock Holdings in Corteva, Inc. $CTVA

Dearborn Partners LLC trimmed its holdings in Corteva, Inc. (NYSE:CTVA) by 3.4% during the fourth quarter, Holdings Channel reports. The firm owned 454,522 shares of the company’s stock after selling 15,920 shares during the quarter. Corteva comprises about 1.5% of Dearborn Partners LLC’s holdings, making the stock its 20th largest position. Dearborn Partners LLC’s holdings in Corteva were worth $30,467,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. JPL Wealth Management LLC bought a new stake in Corteva in the 3rd quarter valued at about $25,000. Redmont Wealth Advisors LLC bought a new stake in Corteva in the 3rd quarter valued at about $29,000. Jackson Grant Investment Advisers Inc. increased its position in Corteva by 90.6% in the 3rd quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock valued at $30,000 after buying an additional 213 shares in the last quarter. Basepoint Wealth LLC bought a new stake in Corteva in the 4th quarter valued at about $30,000. Finally, KERR FINANCIAL PLANNING Corp bought a new stake in Corteva in the 3rd quarter valued at about $33,000. 81.54% of the stock is owned by institutional investors.

Corteva Stock Performance

Shares of CTVA opened at $77.06 on Friday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. The stock has a 50 day moving average price of $81.17 and a two-hundred day moving average price of $74.94. The firm has a market capitalization of $51.54 billion, a P/E ratio of 45.33, a P/E/G ratio of 2.36 and a beta of 0.57. Corteva, Inc. has a 52 week low of $60.53 and a 52 week high of $85.63.

Corteva (NYSE:CTVA) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. The firm had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The company’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same period in the previous year, the company posted $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Monday, June 1st. Corteva’s payout ratio is currently 42.35%.

Wall Street Analysts Forecast Growth

CTVA has been the subject of a number of research analyst reports. Wall Street Zen lowered Corteva from a “buy” rating to a “hold” rating in a research report on Saturday, February 7th. The Goldman Sachs Group boosted their target price on Corteva from $88.00 to $96.00 and gave the company a “buy” rating in a research report on Tuesday, April 14th. Oppenheimer boosted their target price on Corteva from $86.00 to $89.00 and gave the company an “outperform” rating in a research report on Wednesday, April 22nd. UBS Group boosted their target price on Corteva from $88.00 to $90.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. Finally, Rothschild & Co Redburn boosted their target price on Corteva from $80.00 to $90.00 and gave the company a “neutral” rating in a research report on Wednesday, April 29th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Corteva has an average rating of “Moderate Buy” and a consensus target price of $88.67.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.